Pathological conditions, signs and symptoms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Older than 18 years; Rhinosinusitis without polyps or rhinosinusitis with polyps, according to the EPOS 2012 research criteria; Never submitted to nasal or nasosinusal surgery; Indication of surgical treatment due to failure to initial routine clinical treatment.
Exclusion criteria
Exclusion criteria: Inability to answer the questionnaires; Pregnant or lactating women; Absolute contraindication to the use of corticosteroids; Previous diagnosis of immunodeficiencies; Previous diagnosis of nasosinusal neoplasms; Previous diagnosis of primary ciliary dyskinesias; Previous diagnosis of cystic fibrosis; Use, in the 30 days prior to the inclusion in the study, of oral, intramuscular or intravenous corticosteroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| More marked improvement in the level of disease control (assessed according to EPOS 2020), parameters in a quality of life questionnaire (SNOT-22) and specific physical examination (nasal endoscopy using the Lund-Kennedy score) in patients who used nasal irrigation with corticosteroids compared to patients who used nasal spray with corticosteroids. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease in the number of exacerbations of Chronic Rhinosinusitis and postponing nasosinusal surgery in patients who used nasal irrigation with corticosteroids compared to patients who used nasal spray with corticosteroids. | — |
Countries
Brazil
Contacts
ICT Instituto de Ciência e Tecnologia - Unesp de São José dos Campos;Universidade Federal de São Paulo